What do systematic reviews say?

Serious adverse events · patients with Crohn's disease (active disease population with clinical response at baseline)

Serious adverse events · patients on HD with HCV infection

Serious adverse events · children with sickle cell anaemia and microalbuminuria

Serious adverse events · people with sickle cell disease

Serious adverse events · premenopausal women (age 18–32.7 years)

Serious adverse events · premenopausal women (ages 18–36 years)

Serious adverse events · premenopausal women (age 18−47.3 years)

Serious adverse events · adults with central sleep apnoea associated with heart failure

Serious adverse events · adults with central sleep apnoea associated with heart failure

Serious adverse events · adults with primary central sleep apnoea

Serious adverse events · adults with central sleep apnoea associated with heart failure

Serious adverse events · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and an intermediate or poor risk according to the International…

Serious adverse events · people with a confirmed diagnosis of advanced renal cell carcinoma (RCC) and a favourable risk according to the International Metastatic…

Serious adverse events · people with vestibular migraine

Serious adverse events · adults with PPPD

Serious adverse events · Ménière’s disease

Serious adverse events · Ménière’s disease

Serious adverse events · Ménière’s disease

Serious adverse events · Ménière’s disease

Serious adverse events · Ménière’s disease